Advertisement
SAN DIEGO, Dec. 12, 2019 /PRNewswire-PRWeb/ -- Transcranial Magnetic Stimulation (TMS) treatment has great potential to help people suffering from depression, but they need to be better informed of its many benefits, according to a new survey commissioned by Achieve TMS, a leading TMS provider in the United States.
The online survey canvassed about 300 adults with depression in California, Oregon and Alaska on their feelings about depression treatments. Those treatments included medication and therapy, as well as TMS, which is an FDA-approved, MRI-guided neuro-navigation system that sends magnetic pulses to the brain to stimulate neural activity and relieve symptoms of depression, OCD and other conditions. In regards to TMS, the survey found:
About Achieve TMS
Achieve TMS is a leading and highly trusted provider of Transcranial Magnetic Stimulation (TMS), approved in 2013 by the Food and Drug Administration for treating patients with depression. For more information, visit https://achievetms.com/.
SOURCE Achieve TMS
Advertisement
The online survey canvassed about 300 adults with depression in California, Oregon and Alaska on their feelings about depression treatments. Those treatments included medication and therapy, as well as TMS, which is an FDA-approved, MRI-guided neuro-navigation system that sends magnetic pulses to the brain to stimulate neural activity and relieve symptoms of depression, OCD and other conditions. In regards to TMS, the survey found:
- 65% of the people surveyed had not heard about TMS treatment for depression.
- 73.9% of respondents had not heard of the benefits of TMS.
- 10.8% of people surveyed were "very confident" that TMS is a viable treatment option for medically resistant depression, while another 15.3% said they were "confident" in the treatment.
- 21.2% of people believed TMS treatment methods are backed by solid research.
About Achieve TMS
Achieve TMS is a leading and highly trusted provider of Transcranial Magnetic Stimulation (TMS), approved in 2013 by the Food and Drug Administration for treating patients with depression. For more information, visit https://achievetms.com/.
SOURCE Achieve TMS